Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BlueNord:Positive Preliminary Results on HEMJ Well

Oslo, 29 October 2024: Reference is made to stock exchange notice published on 17 June 2024 by BlueNord ASA (“BlueNord” or the “Company”) about the successful spudding of the Harald East Middle Jurassic (“HEMJ”) step-out well in the Eastern part of the producing field Harald.  The Company is pleased to announce that the well has been successfully drilled and is expected to be completed for production shortly. The well encountered 48 meters of good quality sand reservoir containing gas condensate. The well is expected to be brought on stream this year in connection with the Tyra start-up.

Rightbridge acquire the mobile gaming studio Raketspel Innovativa Produkter AB

2024-10-29 Rightbridge Ventures Group AB “Rightbridge” has entered into a share purchase agreement regarding the acquisition of Raketspel Innovativa Produkter AB “Raketspel”. The purchase price is 79 000 000 SEK and will be divided into three sections. 15 million sek in newly issued shares at a 0,06 share price 19,5 million sek loan convertible note with a maturity of three years and a debt exchange of 44,5 million sek from Safe Lane Gaming. The transaction is conditioned upon the bank approving the debt exchange from Safe Lane Gaming to Rightbridge Ventures GroupRaketspel is a Swedish

Eevia Health receives multiple sales orders for c. KSEK 702 (KEUR 61)

Eevia Health Plc ("Eevia" or "The Company") received several sales orders for extracts totaling KEUR 61 from various European customers.Several customers placed a total of KEUR 61 in sales orders. The orders came from the distributor in Germany and a customer in Central Europe, in total KEUR 29 for Feno-Myrtillus 36 Organic and Feno-Myrtillus 25 (Bilberry Extract). One Finnish customer placed an order for a contract manufacturing project, KEUR 6. Furthermore, a French trading partner ordered Feno-Myrtillus 25 (Bilberry Extract), KEUR 26. The trading partner is known for delivering high-

Skanska constructs new hospital in Fort Myers, Florida, USA, for USD 435M, about SEK 4.6 billion

Skanska has signed a contract with Lee Health for the construction of a new hospital and medical office building in Fort Myers, Florida, USA. The contract is worth USD 435M, about SEK 4.6 billion, which will be included in the US order bookings for the fourth quarter of 2024.The project consists of constructing an approximately 38,600 square meter (416,000-square-foot), five story hospital, a central energy plant, and a 11,600 square meter (125,000-square-foot) medical office building which includes an ambulatory surgery center. The project scope includes over a dozen operating rooms,

Loomis Interim Report January – September 2024

Solid performance and strong operating cash flowLoomis delivered solid financial results for the third quarter. Revenue exceeded SEK 7.6 billion with growth across all business lines when adjusting for changes in exchange rates, except for the International business line where we are still experiencing cyclical headwinds. We continue to see double-digit organic growth for Automated Solutions in both regions, where the performance of CIMA also has a positive contribution on the results.  The operating income (EBITA) of SEK 981 million is our highest ever and we increased our operating

HANZA interim report January-September 2024

HANZA reports a continued strong financial development in the third quarter, the operating margin increased to 6.7% compared to 5.7% in Q2. During the quarter, the company decided on a final part of the action program that has been ongoing during 2024. The one-time cost amounts to SEK 33 million and is balanced against a non-recurring income from a reduced purchase price for the acquisition of Orbit One. HANZA sees a very good profitability increase in the units from Orbit One and reiterates the margin target of at least 8% for the full year 2025.Third quarter 2024 · Net sales

Wärtsilä’s Interim Report January–September 2024

Wärtsilä Corporation, Interim Report January–September 2024, 29 October 2024 at 8:30 (EET)Wärtsilä’s Interim Report January–September 2024 This release is a summary of Wärtsilä’s Interim Report January–September 2024. The complete report is attached to this release as a pdf file. It is also available on the company website at www.wartsila.com. IMPROVED NET SALES, PROFITABILITY AND CASH FLOW Highlights from July–September 2024 · Order intake remained stable at EUR 1,803 million (1,787), while the organic growth, which excludes FX impact and the impact of acquisitions and

Per Elfgren appointed new head of SSAB Special Steels

Per Elfgren has been appointed new head of SSAB Special Steels. He takes up the new position from his present role as head of Market Development at SSAB Special Steels. Per Elfgren has extensive international experience of leading positions with responsibility for marketing, sales and product development, for example. For the past eight years, he has been a member of SSAB Special Steels’ Management Team and has been responsible for market development and for Abraservice, a fully-owned SSAB company. Per Elfgren joined SSAB in 1996. “Per has played a major role in taking SSAB

AMSC ASA - Third quarter 2024 results

Lysaker, 29 October 2024, AMSC ASA (“AMSC” or the “Company”) announces results for the third quarter ending 30 September 2024. HIGHLIGHTS: · Acquired an additional 980 000 shares in Solstad Maritime Holding AS (“Solstad Maritime”). · Recognized share of profit of NOK 156.4 million relating to the investment in Solstad Maritime. · Expect to receive NOK 45.7 million in dividends from Solstad Maritime during Q4. · AMSC increases quarterly dividends to NOK 0.60 per share. AMSC CEO, Pål Lothe Magnussen comments, “We are pleased to increase our quarterly dividends to NOK 0.60

Arctic Bioscience – Q3 2024 Operational update

Highlights Q3 2024: · The HeROPA 6-month read-out showed an effect close to the assumed effect level in the high dose active treatment arm, while the placebo rate was unexpectedly high, preventing the achievement of the primary end-point. The HeROPA study is still ongoing and placebo controlled for 52 weeks ending Q1 2025 · Nutra revenues YTD Q3 are NOK 27,8 million (NOK 23,9 million), expecting a growth of 25-30 % end of 2024 compared to 2023 · Asian markets with strong development; expecting 65-70 % growth compared to 2023 · European market also developing well; expecting 45 %

Tiny gold radiators fry bacteria on implants

   In the fight against antibiotic resistance, a new technology developed at Chalmers University of Technology, in Sweden, can be of great importance when, for example, hip and knee implants are surgically inserted. By heating up small nanorods of gold with near-infrared light (NIR), the bacteria are killed, and the surface of the implant becomes sterile. The researchers are now presenting a new study that increases the understanding of how the gold rods are affected by light and how the temperature in them can be measured. Infections can occur during surgical procedures, with

Interim Report 9 months - 1 January-30 September 2024

Third quarter (1 Jul-30 Sep 2024) · Net sales increased by 2 percent to MSEK 1,553 (1,529). Currency-adjusted sales rose by 4 percent. · Operating profit before depreciation and amortisation (EBITDA) excluding non-recurring items of MSEK -21 (0) amounted to MSEK 154 (180). 1) · Operating profit amounted to MSEK 69 (129) and the operating margin was 4.4 percent (8.5). Operating profit was charged with non-recurring items of MSEK -21 (0). 1) · Profit after financial items totalled MSEK 73 (113). 1) · Profit after tax amounted to MSEK 50 (79). · Earnings per share before

Orkla reports strong profit improvement

Orkla achieved EBIT (adj.) of NOK 2.1 billion in the third quarter of 2024, up 13% on the same period last year.Group operating revenues rose by 4.3% in the third quarter of 2024, year-over-year, and volume growth was positive for the third successive quarter. Orkla’s consolidated portfolio companies (including HQ and Business Service) grew EBIT (adj.) by 20%, to NOK 2.0 billion, in the third quarter of the year. The increase was broad-based across the consolidated portfolio companies, driven by organic revenue growth, margin improvement and positive mix effects. Adjusted earnings per

Presentation of 3[rd] quarter 2024 results

Key financials:  · Adjusted EBITDA in Solstad Offshore ASA of NOK 328 million and Solstad Maritime Holding AS of NOK 975 million · Solstad Maritime Holding AS initiates quarterly dividend payments from Q3 2024 of NOK 0.50/share, totaling NOK ~233 million. · Solstad Offshore’s share of the dividend amount is NOK ~64 million · High utilization of 97% in the quarter Skudeneshavn, Oct 29nd, 2024 Contacts Lars Peder Solstad CEO, at +47 91 31 85 85 Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASA www.solstad.com This information is subject of the

Eficode recognized as GitHub EMEA Channel Partner of the Year 2024 award winner

Helsinki, Finland, October 28, 2024 - Eficode, a leading DevOps company, has been awarded GitHub Channel of the Year in the EMEA Platform category at the prestigious GitHub Channel Partner of the Year Awards 2024. This award recognizes Eficode’s exceptional contributions, innovation, and dedication to delivering solutions that enable success for mutual customers within the GitHub ecosystem.This recognition underscores Eficode’s ongoing commitment to empowering organizations across Europe, United Kingdom, and the United States with innovative DevOps practices and seamless integration with

Read original

ShaMaran Reports Market Purchase and Cancellation of Bonds

VANCOUVER, BC, Oct. 28, 2024 /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (TSXV: SNM) (Nasdaq First North: SNM) announces the market purchase and cancellation of $2.1 million of the Company’s 12% senior unsecured bond (ISIN NO0011057622) (the “Bond”). The total outstanding amount of the Bond as of the date of this press release is $200.0 million.   ShaMaran plans to publish its financial statements for the nine months ending September 30, 2024, on November 7, 2024. Except as otherwise indicated, all currency amounts indicated as “$” in this news release are expressed

Rightbridge Ventures Group and Oceanview Announce Mutual Termination of Share Purchase Agreement - Claes Kalborg reinstated as CEO

Rightbridge Ventures Group AB (“Rightbridge”) and Oceanview Group Limited (“Oceanview”) jointly announce the mutual termination of their share purchase agreement, initially signed on June 24, 2024. This agreement, which involved Rightbridge’s acquisition of 51% of Oceanview, has been concluded based on a shared belief that the timing and strategic alignment are not optimal for either company. Thiago De Freitas steps down as CEO as part of the termination process and the board of directors has reinstated Claes Kalborg as CEO of Rightbridge Ventures Group.Both the board of directors in

Nordea Bank Abp: Repurchase of own shares on 28.10.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares28.10.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 28.10.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |139,754|10.90 |1,524,003.

CS MEDICA A/S: Notice of Extraordinary General Meeting

The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meeting to be held on Tuesday, 12 November 2024, at 15:00 via TEAMS.Proposed Agenda 1. Election of the chairman of the meeting. 2. Distribution of CANNORDIC Shares to CS MEDICA ShareholdersProposal to distribute 1 share in CANNORDIC for every 200 shares held by CS MEDICA shareholders as of the EGM date. Additionally, all shareholders will be offered the opportunity to purchase pre-IPO shares at a 20% discount. 3. Conversion of Receivables in CANNORDIC A/SProposal to

The Board of Loomis has resolved to continue to repurchase shares

The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the Annual General Meeting 2024. The repurchase may commence on October 30, 2024, end no later than on December 20, 2024, and comprise an amount up to a maximum of SEK 200 million. Repurchase shall be made on Nasdaq Stockholm, on one or more occasions, at a price within the prevailing price interval registered at each point in time (being the interval between the highest buying price and the lowest selling price). Payment for repurchased shares shall be made in cash. Danske

There are no items matching the current filter
There are no more items matching the current filter
Back to top